Press Archives - 4E Therapeutics Inc

4E Therapeutics Awarded NIH Research Grant to Develop Non-Opioid Treatment for Pain to End Addiction

AUSTIN, TX – Nov. 10, 2021 /PRNewswire/ -- 4E Therapeutics, Inc., a neuroscience company based in Austin, Texas developing a first-in-class treatment for neuropathic pain, announced that it has been awarded a…

Lindsay Huck In Press

4E Therapeutics Receives Grant from NIH

AUSTIN, TX – 4E Therapeutics, Inc., a neuroscience company developing a first-in-class treatment for neuropathic pain, announced that it has been awarded a National Institutes of Health (NIH) Small Business…

Publications

The Journal of Neuroscience

August 2, 2017

The MNK–eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic Pain

Download Now

Trends in Neurosciences

February 01, 2018

Translational Control Mechanisms in Persistent Pain

Download Now

The Journal of Neuroscience

January 16, 2019

Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic Pain

Download Now

Biological Sciences

September 23, 2019

MNK-eIF4E signalling is a highly conserved mechanism for sensory neuron axonal plasticity: evidence from Aplysia californica

Download Now

Neuropsychopharmacology

October 07, 2019

Reversal of peripheral nerve injury-induced neuropathic pain and cognitive dysfunction via genetic and tomivosertib targeting of MNK

Download Now

Pharmacological Reviews

January, 2021

Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain

Download Now